Crizotinib administered via nasogastric and percutaneous endoscopic gastrostomy tubes for the successful treatment of ALK-rearranged lung cancer in a.

Slides:

Advertisements

Similar presentations

Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan.

Advertisements

A long-term survivor of non-small-cell lung cancer harboring concomitant EGFR mutation and ALK translocation Fumio Imamura, Takako Inoue, Madoka Kimura,

Ahsan R. Akram, John H. Reid, William Wallace, Simon W

Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD

Steroid-related emphysematous cystitis in an EGFR-mutant patient with lung adenocarcinoma while on gefitinib treatment Diego Marquez-Medina, Sanjay Popat

Hiromasa Nakayasu, Toshihiro Shirai, Yuko Tanaka, Mika Saigusa

Lung cancer in patients diagnosed with silicosis should be investigated Adil Can Güngen, Yusuf Aydemir, Hikmet Çoban, Hasan Düzenli, Canantan Tasdemir

Esophageal adenocarcinoma five years after laparoscopic sleeve gastrectomy. A case report Fernando Gabriel Wright, Agustin Duro, Juan Rodolfo Medici,

Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma Qiushi Wang, Xin Yang, Yong He, Qiang Ma, Li Lin,

Secondary Mutations at I1171 in the ALK Gene Confer Resistance to Both Crizotinib and Alectinib Gouji Toyokawa, MD, PhD, Fumihiko Hirai, MD, PhD, Eiko.

Peritonitis Secondary to the Migration of a Trans-Hepatically–Placed Percutaneous Endoscopic Gastrostomy Tube: A Case Report David T. Burke, MD, MA,

Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography Walter.

Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer

Hiren J. Mehta, MD, Tan-Lucien Mohammed, MD, Michael A. Jantz, MD

A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size Shigeki Suzuki, MD, Hiroyuki Sakurai, MD, Kyohei.

Primary pulmonary hepatoid adenocarcinoma: A case report

ALK FISH and IHC: You Cannot Have One without the Other

Palliative Neck Surgery in Metastatic Lung Cancer: A Case Report

Oxygen-Exacerbated Bleomycin Pulmonary Toxicity

Afatinib-Induced Severe Interstitial Lung Disease Successfully Treated with High-Dose Corticosteroid Therapy: A Case Report Kazutaka Fujita, MD, Yuko.

Mammalian Target of Rapamycin Inhibitors in Clinical Practice: Case Reports of Everolimus in Renal Cell Carcinoma Sergio Bracarda, Alain Ravaud, Marino.

Anthracotic Intrapulmonal Lymph Nodes Mimicking Lung Metastases

Video-Assisted Mediastinoscopic Lymphadenectomy for Staging Non-Small Cell Lung Cancer Sergi Call, MD, Carme Obiols, MD, PhD, Ramon Rami-Porta, MD, PhD,

Unexpected Small Bowel Intussusception Caused by Lung Cancer Metastasis on 18F- Fluorodeoxyglucose PET-CT Jeong Won Lee, MD, Seok-Ki Kim, MD, Ji Won Park,

The True False Negative Rates of Esophageal and Endobronchial Ultrasound in the Staging of Mediastinal Lymph Nodes in Patients With Non-Small Cell Lung.

First-Line Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status Young Joo Lee, MD, Heung Tae Kim, MD,

Tumor-to-Tumor Metastasis: Maxillary Sinus Adenoid Cystic Carcinoma Metastasizing to Double Primary Lung Adenocarcinoma Wei-Yang Lin, MD, Wen-Hu Hsu,

A Prospective Study of Surgical Procedures for Patients With Oligometastatic Non-Small Cell Lung Cancer Chiaki Endo, MD, PhD, Tohru Hasumi, MD, PhD,

Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer

Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer Hiroyasu Kaneda, MD, PhD, Isamu.

Complete Response Achieved 1 Year after a Single Administration of Nivolumab in a Patient with Lung Adenocarcinoma with Negative Expression of PD-L1

Successful Crizotinib Retreatment after Crizotinib-Induced Interstitial Lung Disease Satoru Yanagisawa, MD, PhD, Akira Inoue, MD, PhD, Akira Koarai, MD,

Surgical treatment of metachronous second primary lung cancer after complete resection of non–small cell lung cancer Masatsugu Hamaji, MD, Mark S. Allen,

Primary Tracheal Lymphoma Causing Respiratory Failure

Atypical Pleuropulmonary Tuberculosis Mimicking a Malignant Disease

Successful Treatment with Erlotinib after Gefitinib-Induced Severe Interstitial Lung Disease Masayuki Takeda, MD, PhD, Isamu Okamoto, MD, PhD, Chihiro.

Superselective Segmentectomy for Deep and Small Pulmonary Nodules Under the Guidance of Three-Dimensional Reconstructed Computed Tomographic Angiography

Effective Treatment with Icotinib in Primary Adenoid Cystic Carcinoma of the Lung with Liver Metastasis Zhengbo Song, MD, Wei Wu, MD, Yiping Zhang, MD

Evaluating Cryoablation of Metastatic Lung Tumors in Patients—Safety and Efficacy The ECLIPSE Trial—Interim Analysis at 1 Year Thierry de Baere, MD,

Disease Flare After Treatment Discontinuation in a Patient With EML4-ALK Lung Cancer and Acquired Resistance to Crizotinib Oana Pop, MD, Augustin Pirvu,

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients with Non-small Cell Lung Cancer in Nonoperable Patients.

Histology and Smoking Status Predict Survival of Patients with Advanced Non–Small- Cell Lung Cancer: Results of West Japan Oncology Group (WJOG) Study.

Thymic and Mediastinal Lymph Node Metastasis of Colon Cancer

Transformation to SCLC after Treatment with the ALK Inhibitor Alectinib Shiro Fujita, MD, PhD, Katsuhiro Masago, MD, PhD, Nobuyuki Katakami, MD, PhD,

Ineffectiveness of Crizotinib on Brain Metastases in Two Cases of Lung Adenocarcinoma with EML4-ALK Rearrangement Denis Maillet, MD, Isabelle Martel-Lafay,

Frequency of Lymph Node Metastasis According to the Size of Tumors in Resected Pulmonary Adenocarcinoma with a Size of 30 mm or Smaller Yangki Seok,

Computed tomography evaluation of aortic remodeling after endovascular treatment for complicated ulcer-like projection in patients with type B aortic.

A Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to Crizotinib Yoon Jin Cha, MD, PhD, Byoung Chul.

Combination Treatment Using an EGFR Tyrosine Kinase Inhibitor plus Platinum-Based Chemotherapy for a Patient with Transformed Small Cell Carcinoma and.

ALK Translocation in Non-small Cell Lung Cancer with Adenocarcinoma and Squamous Cell Carcinoma Markers Samuel J. Klempner, MD, David W. Cohen, MD, Daniel.

Volume 17, Issue 2, Pages (February 1950)

Expanded Circulating Tumor Cells from a Patient with ALK-Positive Lung Cancer Present with EML4-ALK Rearrangement Along with Resistance Mutation and Enable.

Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki,

Surgical Treatment for Limited-Stage Primary Small Cell Cancer of the Esophagus Dongrong Situ, MD, Yongbin Lin, MD, PhD, Hao Long, MD, PhD, Lanjun Zhang,

Early Immune-Related Adverse Events and Association with Outcome in Advanced Non–Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective.

Endobronchial and Endoscopic Ultrasound-Guided Transvascular Biopsy of Mediastinal, Hilar, and Lung Lesions Jordan Kazakov, MD, Pravachan Hegde, MD,

Concomitant Epidermal Growth Factor Receptor Mutation and EML4-ALK Fusion in a Patient with Multifocal Lung Adenocarcinomas Jun Fan, MD Journal of Thoracic.

Descending necrotizing mediastinitis: An analysis of the effects of serial surgical debridement on patient mortality Richard K. Freeman, MD, Eric Vallières,

Thoracic Surgery Survey on Lung Cancer Management

S-1 Treatment for Chemorefractory Thymic Carcinoma

Cytokeratin 19 Fragment Predicts the Efficacy of Epidermal Growth Factor Receptor– Tyrosine Kinase Inhibitor in Non–Small-Cell Lung Cancer Harboring EGFR.

The Current Status of Traumatic Diaphragmatic Injury: Lessons Learned From 105 Patients Over 13 Years Waël C. Hanna, MD, Lorenzo E. Ferri, MD, Paola.

Spontaneous Pneumothorax

Sequential Mediastinal Lymphadenectomy of an Unknown Primary Tumor

David Garfield, MD Journal of Thoracic Oncology

Mark I. Block, MD The Annals of Thoracic Surgery

Adding Bevacizumab to Chemotherapy Effectively Control Radioresistant Brain Metastases in ALK-Positive Lung Adenocarcinoma Yu-Li Su, MD Journal of Thoracic.

Nodal Recurrence of Pulmonary Carcinoid 30 Years After Primary Resection Abdel-Mohsen Hamad, MD, Giovanna Rizzardi, MD, Giuseppe Marulli, MD, Federico.

A Dramatic Response to Crizotinib in a Non–Small-Cell Lung Cancer Patient with IHC- Positive and FISH-Negative ALK Jong-Mu Sun, MD, PhD, Yoon-La Choi,

Patterns-of-Care for Thoracic Stereotactic Body Radiotherapy among Practicing Radiation Oncologists in the United States Megan E. Daly, MD, Julian R.

Presentation transcript:

Crizotinib administered via nasogastric and percutaneous endoscopic gastrostomy tubes for the successful treatment of ALK-rearranged lung cancer in a patient with poor performance status Koji Tamai, Kazuma Nagata, Kyoko Otsuka, Atsushi Nakagawa, Ryo Tachikawa, Kojiro Otsuka, Nobuyuki Katakami, Keisuke Tomii Respiratory Investigation Volume 51, Issue 1, Pages 46-48 (March 2013) DOI: 10.1016/j.resinv.2012.12.001 Copyright © 2012 The Japanese Respiratory Society Terms and Conditions

Fig. 1 (A) A chest X-ray showing the primary lung adenocarcinoma lesion. (B) A chest X-ray obtained on the 24th day after the initiation of crizotinib treatment. Respiratory Investigation 2013 51, 46-48DOI: (10.1016/j.resinv.2012.12.001) Copyright © 2012 The Japanese Respiratory Society Terms and Conditions

Fig. 2 (A) Chest computed tomography (CT) showing enlarged mediastinal lymph nodes, indicating metastasis and the primary lesion. (B) Chest CT obtained on the 31st day after the initiation of crizotinib treatment. Respiratory Investigation 2013 51, 46-48DOI: (10.1016/j.resinv.2012.12.001) Copyright © 2012 The Japanese Respiratory Society Terms and Conditions